Needham Raises Teleflex to Buy Citing Divestiture-Driven Upside
Needham upgraded Teleflex from Hold to Buy and set a $138 price target after the medical-device company announced plans to divest three business units. Teleflex expects roughly $1.8 billion in after-tax proceeds from sales that are slated to close in the second half of 2026, and the research house anticipates those proceeds will fund share repurcha…